INTRODUCTION
Rhabdomyosarcoma is a rare tumor, with an annual incidence of 4.3 cases per million children (1) . Even thought, it is the most common soft tissue sarcoma in childhood, with a mean age of 6 to 8 years at diagnosis (1) . It can occur in any anatomic location of the body where there is skeletal muscle, as well as other sites without skeletal muscle, such as the soft tissues of the orbit. It is presumed that most of these lesions, particularly the embryonal variants, arise from undifferentiated or pluripotential mesenchyme. The primary sites of rhabdomyosarcoma include (2) head and neck (40%), genitourinary tract (20%), extremities (20%), trunk (10%) and others (10%). In the eye, it can affect orbit, eyelids, conjunctiva and uveal tract (3) (4) (5) . Rhabdomyosarcomas of the conjunctiva without orbital extension are rarely reported (2, 6) . We presented a case of a child with a rare tumor which we had a high suspicion of malignancy and early diagnosis and treatment, and child is free of systemic disease 6 and half years later.
CASE REPORT
A 4 year-old boy presented in our institution with a history of a fast growing (1-month) nodular lesion in the caruncle of his left eye. Slit lamp examination showed a vascularized solid nodular lesion in the se milunar fold (Figure 1 ). Otherwise ocular examination was unremarkable and no other conjunctival or ocular lesions were observed. Systemic studies were negative.
Familial history showed a cousin died due to a rhabdomyosarcoma of the biliary tract.
The lesion was surgically removed obtaining infiltrated edges with tumoral cells, second surgery was made with free tumor edges. Ad juvant polichemotherapy treatment, following the Protocol of the International Society of Pedriatric Oncology for Malignant Mesenchymal Tumors, was performed using ifosfamide, vincristine, and actinomycin (IVA) -vincristine (V) in alterned cicles for 7 cicles. ABSTRACT Rhabdomyosarcoma is a rare tumor, with an annual incidence of 4.3 cases per mil lion children. Even thought, it is the most common soft tissue sarcoma in childhood, with a mean age of 6 to 8 years at diagnosis. A 4 year-old boy presented with a history of a fast growing (1-month) nodular lesion in the caruncle of his left eye. Slit lamp examination showed a vascularized solid nodular lesion in the semilunar fold. The lesion was surgically removed obtaining infiltrated edges with tumoral cells. A second surgery was performed with free tumour edges. The diagnosis of embryonal rhabdomyosarcoma, botryoid type, of intermediate differentiation was made. The treatment for botryoid rhabdomyosarcoma is basically surgical with the combined use of adjuvant polychemotherapy. In adolescent or adult patients (not in infants where growth bone disturbances can occur) external beam radiotherapy can be combined with chemotherapy. Rhabdomyosarcomas of the conjunctiva without orbital extension are rarely reported. We presented a case of a child with a rare tumor which we had a high suspicion of malignancy and early diagnosis and treatment and child is free of systemic disease 6 and half years later. Our research group believes that the key in these tumors is the high index of suspicion and early treatment. 
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RESULTS
A polipoid lesion, with an intact conjunctival epithelium was seen (Figure 2 ). There were tumoral cells in the substantia propia, and in so me areas they were aggregated as a denser layer beneath the epithelium (Figure 3) . At higher magnification the undifferentiated tumor was composed of loosely coherent spindle-shaped cells, some of them with red-staining citoplasms, oriented in various directions. The cellular atypia and pleomorphism were evident, and there was a high proliferative rate (60-70%). Cross striations were not readily visua lized. There was an image highly suggestive of lymphatic invasion.
On immunohistochemistry many tumour cells showed strong reac tivity with vimentine (Figure 4) , muscle-specific actin and desmin antibodies and to a lesser extent with an antibody against Myo-D1.
The diagnosis of embryonal rhabdomyosarcoma, botryoid type, of intermediate differentiation was made.
DISCUSSION
Rhabdomyosarcoma originating in the conjunctiva show a propensity to arise in the superior or superonasal areas of the conjunctival cul-de-sac, but they also may arise in other quadrants. The initial clinical manifestation of the tumor may be as a noninflamed pedicle of soft tissue originating in the fornix and protruding into the palpebral aperture. A botryoid rhabdomyosarcoma clinically does not necessarily show rapid growth.
Based on histopathologic observation, these tumors have been subdivided into embryonal (83%), alveolar (15%), and pleomorphic ("adult type") forms (2%). Patient survival correlate with the morphologic subtype at diagnosis (7) (embryonal rhabdomyosarcoma has the more favorable prognosis 1 ). CT and MR imaging are important in the evaluation of this tumor but final histophthological diagnosis is based in immunohistologic reactivity for desmin and myoglobin, two muscle-related proteins (6) . Rhabdomyosarcoma may also be encountered in the rare LiFrau meni syndrome, in which there is a predisposition to the de velop ment of various neoplasia, including sarcoma, breast carcinoma, cen tral nervous system tumors, germ cell tumors, and leukemia. A mu tation of the p53 suppressor gene has been identified as the causa tive factor. Patients with Li-Fraumeni syndrome not only present with neoplasia at an earlier age and have a worse prognosis than does the general population, but also have an increased risk for the development of secondary malignancies within the radiation field.
The treatment for botryoid rhabdomyosarcoma is basically sur gical with the combined use of adjuvant polychemotherapy. In adolescent or adult patients (not in infants where growth bone disturbances can occur) external beam radiotherapy can be combined with chemothe- rapy. Some authors (1) , due to the post-radiation complications, pro pose to use radiotherapy only in cases with bad response to che motherapy (1) . There is an innovative therapeutic approach for a rhabdomyosarcoma with brachytherapy with strontium-904, whose adva ntage is the high surface dose combined with a minimal depth of irradiation.
Our research group believes that the key in these tumors is the high index of suspicion and the early treatment, and in our knowled ge there is no publish report of such extremely rare case with favorable evolution.
